drugset / Trial / NCT06613698
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NaSequentialDouble-blindTreatment
Summary
The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.
Timeline
- Start
- 2024-09-27
- Primary completion
- 2027-08-02
- Completion
- 2028-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK4532990 | Unknown | — | — |